We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Run Endocrine Effect Tests Before Starting Clinical Studies
FDA: Run Endocrine Effect Tests Before Starting Clinical Studies
September 30, 2013
Before investing time and money on a drug in clinical trials, sponsors should run a battery of nonclinical tests to see if the candidate has an effect on the endocrine system, and if further nonclinical tests and clinical endpoints are needed to determine the drug’s safety, says the FDA.